Risk‐tailored CNS prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era
Publisher： John Wiley & Sons Inc
E-ISSN： 1365-2141|168|5|654-662
ISSN： 0007-1048
Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.5, 2015-03, pp. : 654-662
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
